Reciprocal regulation of cyclooxygenase-2 and 15-hydroxyprostaglandin dehydrogenase expression in A549 human lung adenocarcinoma cells

Carcinogenesis

Volumn 27, Issue 11, 2006, Pages 2170-2179

  Tong, Min ^a   Ding, Yunfei ^a   Tai, Hsin Hsiung ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INTERLEUKIN 1BETA; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; ARTICLE; CANCER CELL CULTURE; CELL CLONE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME SPECIFICITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; WESTERN BLOTTING;

ADENOCARCINOMA; ADENOVIRIDAE; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; RNA, SMALL INTERFERING;

EID: 33750443959     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl053     Document Type: Article

References (47)

1. DuBois,R.N., Abramson,S.B., Crofford,L., Gupta,R.A., Simon,L.S., VandePutte,L.B.A. and Lipisky,P.E. (1998) Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073.
2. Smith,W.L., DeWitt,D.L. and Garavito,R.M. (2000) Cyclooxygenases: structural, cellular and molecular biology. Annu. Rev, Biochem., 69, 145-182.
3. Vane,J.R., Bakhle,Y.S. and Botting,R.M. (1998) Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol., 38, 97-120.
4. Subbaramaiah,K. and Dannenberg,A.J. (2003) Cyclooxygenase-2: A molecular target for cancer prevention and treatment. Trends Pharmacol. Sci., 24, 96-102.
5. Cok,S.J. and Morrison,A.R. (2001) The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translation efficiency. J. Biol. Chem., 276, 23179-23185.
6. Mukhopadhyay,D., Houshen,C.W., Kennedy,S., Dieckgraefe,B.K. and Anant,S. (2003) Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell, 11, 113-126.
7. Sawaoka,H., Dixon,D.A., Oates,J.A. and Boutaud,O. (2003) Tristetraprolin binds to the 3′-untranslated region of cyclooxygenase-2 m-RNA. A polyadenylation variant in a cancer cell line lacks the binding site. J. Biol. Chem., 278, 13928-13935.
8. Tai,H.H., Ensor,C.M., Tong,M., Zhou,H. and Yan,F. (2002) Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid. Mediat., 68/69, 483-493.
9. Anggard,E., Larson,C. and Samuelsson,B. (1971) The distribution of 15-hydroxyprostaglandin dehydrogenase and prostaglandin Δ13-reductase in tissues of the swine. Acta Physiol. Scand., 8, 396-403.
10. Ensor,C.M. and Tai,H.H. (1995) 15-Hydroxyprostgalndin dehydrogenase. J. Lipid Mediat. Cell Signal., 12, 313-319.
11. +-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic (HL-60) cells by phorbol ester. Biochem. J., 279, 553-558.
12. +-dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by dexamethasone and phorbol ester in human erythroleukemia (HEL) cells. Biochem. Biophys. Res. Commun., 177, 1258-1265.
13. +-dependent 15-hydroxyprostaglandin dehydrogenase by phorbol ester in human promonocytic U937 cells. Biochim. Biophys. Acta, 1497, 61-68.
14. Tong,M. and Tai,H.H. (2005) 15-Hydroxyprostglandin dehydrogenase can be induced by dexamethasone and other glucocorticoids at the therapeutic level in A549 human lung adenocarcinoma cells. Arch. Biochem. Biophys., 435, 50-55.
15. +-dependent 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. Biochem. Biophys. Res. Commun., 276, 77-81.
16. +-dependent 15-hydroxyprostaglandin dehydroeganse in human neonatal monocytes. Blood, 89, 2105-2112.
17. Frenkian,M., Segond,N., Pidoux,F., Cohen,R. and Jullienne,A. (2001) Indomethacin, a COX inhibitor, enhances 15-PGDH and decreases human tumoral C cells proliferation. Prostaglandins, 65, 11-20.
18. +-dependent 15-hydroxyprostaglandin dehydrogenase in cultured term human villous trophoblast and chorion trophoblast cells. J. Clin. Endocrinol. Metab., 84, 4645-4651.
19. Maier,J.A., Hla,T. and Maciag,T. (1990) Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem., 265, 10805-10808.
20. Geng,Y., Blanco,F., Cornelisson,M. and Lotz,M. (1995) Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J. Immunol., 155, 796-801.
21. Wolff,H., Saukkonen,K., Anttila,S., Karjalainen,A., Vainio,H. and Ristimaki,A. (1998) Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res., 58, 4997-5001.
22. Bakhle,Y.S. (2001) COX-2 and cancer: A new approach to an old problem. Br. J. Pharmacol., 134, 1137-1350.
23. Yoshimatsu,K., Altorki,N.K., Golijanin,D., Zhang,F., Jakobsson,P.J., Dannenberg,A.J. and Subbaramaiah,K. (2001) Inducible prostaglandin E synthase is overexpressed in non-small cell lung cancer. Clin. Cancer Res., 7, 2669-2674.
24. Heighway,J., Knapp,T., Boyce,L. et al. (2002) Expression profiling of primary non-small cell lung cancer for target identification. Oncogene, 21, 7749-7763.
25. +-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer. Carcinogenesis, 26, 65-72.
26. Celis,J.E., Ostergaard,M., Basse,B. et al. (1996) Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progress of human bladder transitional carcinoma. Cancer Res., 56, 4782-4790.
27. Yan,M., Rerko,R.M., Platzer,P. et al. (2004) 15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-β-induced suppressor of human gastrointestinal cancers. Proc. Natl Acad. Sci. USA, 101, 17468-17473.
28. Backlund,M.G., Mann,J.R., Holla,V.R., Buchanan,F.G., Tai,H.H., Musiek,E.S., Milne,G.L., Katkuri,S. and DuBois,R.N. (2005) 15-Hydroxyprostglandin dehydroegnase is downregulated in colorectal cancer. J. Biol. Chem., 280, 3217-3223.
29. 2. Gut, 35, 675-678.
30. +-dependent 15-hydroxyprostaglandin dehydrogenase. J. Biol. Chem., 265, 14888-14891.
31. +-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim. Biophys. Acta, 1208, 151-156.
32. +-dependent 15-hydroxyprostagalndin dehydrogenase. Biochem. J., 267, 75-78.
33. +-dependent glyceraldehydes 3-phosphate dehydrogenase is a novel substrate for cholera and pertussis toxins in human platelet cytosol. Res. Commun. Cell Biol. Biochem., 1, 21-32.
34. 2 synthesis by interleukin-1β is amplified by interferons but inhibited by interleukin 4 in human amnion-derived WISH cells. Biochim Biophys Acta, 1310, 48-52.
35. 3H] prostaglandins and their use in the development of a simple and sensitive assay for 15-hdroxyprostglandin dehydrogenase. Biochemistry, 15, 4586-4592.
36. Wu,K.K., Zoldhelyi,P., Willerson,J.T., Xu,X.M., Loose-Mitchell,D.S. and Wang,L.H. (1994) Gene therapy for vascular diseases. Tex. Heart. Inst. J., 21, 98-103.
37. Yamamoto,S., Yan,F., Zhou,H. and Tai,H.H. (2001) Serine-331 is the major site of receptor phosphorylation induced by agents that elevate cyclic GMP in HEK cells overexpressing thromboxane receptor. Arch. Biochem. Biophys., 93, 97-105.
38. 1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2 specific RNA interference. Oncogene, 22, 8653-8661.
39. Elbashir,S.M., Harborth,J., Weber,K. and Tuschl,T. (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods, 26, 199-213.
40. Herschman,H.R. (1996) Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299, 125-140.
41. Dixon,D.A., Tolley,N.D., King,P.H., Nabors,L.B., McIntyre,T.M., Zimmerman,G.A. and Prescott,S. (2001) Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest., 108, 1657-1665.
42. Piecyk,M., Wax,S., Beck,A.R. et al. (2000) TIA-1 is a translational silencer that selectively regulates the expression of TNF-alpha. EMBO J., 19, 4154-4156.
43. Singh,R. and Greene,M.R. (1993) Sequence specific binding of transfer RNA by glyceraldehydes-3-phosphate dehydrogenase. Science, 259, 365-368.
44. +-binding fold of glyceraldehydes-3-phosphate dehydrogenase as a novel RNA-binding domain. Biochem. Biophys. Res. Commun., 275, 253-260.
45. +-dependent 15-hydroxyprostaglandin dehydrogenase gene. Biochem. Biophys. Res. Commun., 235, 582-586.
46. +-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone. Endocrinology, 141, 581-597.
47. Lennon,C., Carlson,M.G., Nelson,D.M. and Sadovsky,Y. (1999) In vitro modulation of the expression of 15-hydroxyprostgalndin dehydrogenase by trophoblast differentiation. Am. J. Obstet. Gynecol., 180, 690-695.